Retargeting the Clostridium botulinum C2 toxin to the neuronal cytosol

Benjamin J. Pavlik, Elizabeth J. Hruska, Kevin Van Cott, Paul H Blum

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Many biological toxins are known to attack specific cell types, delivering their enzymatic payloads to the cytosol. This process can be manipulated by molecular engineering of chimeric toxins. Using toxins with naturally unlinked components as a starting point is advantageous because it allows for the development of payloads separately from the binding/translocation components. Here the Clostridium botulinum C2 binding/translocation domain was retargeted to neural cell populations by deleting its non-specific binding domain and replacing it with a C. botulinum neurotoxin binding domain. This fusion protein was used to deliver fluorescently labeled payloads to Neuro-2a cells. Intracellular delivery was quantified by flow cytometry and found to be dependent on artificial enrichment of cells with the polysialoganglioside receptor GT1b. Visualization by confocal microscopy showed a dissociation of payloads from the early endosome indicating translocation of the chimeric toxin. The natural Clostridium botulinum C2 toxin was then delivered to human glioblastoma A172 and synchronized HeLa cells. In the presence of the fusion protein, native cytosolic enzymatic activity of the enzyme was observed and found to be GT1b-dependent. This retargeted toxin may enable delivery of therapeutics to peripheral neurons and be of use in addressing experimental questions about neural physiology.

Original languageEnglish (US)
Article number23707
JournalScientific Reports
Volume6
DOIs
StatePublished - Mar 30 2016

Fingerprint

Cytosol
Immunotoxins
Biological Toxins
Clostridium botulinum
Artificial Cells
Endosomes
Glioblastoma
HeLa Cells
Confocal Microscopy
Flow Cytometry
Proteins
Neurons
Enzymes
Population
botulinum toxin type C
Therapeutics
trisialoganglioside GT1

ASJC Scopus subject areas

  • General

Cite this

Retargeting the Clostridium botulinum C2 toxin to the neuronal cytosol. / Pavlik, Benjamin J.; Hruska, Elizabeth J.; Van Cott, Kevin; Blum, Paul H.

In: Scientific Reports, Vol. 6, 23707, 30.03.2016.

Research output: Contribution to journalArticle

@article{1c67dfde1b054c5a9491ce2e1bf5290e,
title = "Retargeting the Clostridium botulinum C2 toxin to the neuronal cytosol",
abstract = "Many biological toxins are known to attack specific cell types, delivering their enzymatic payloads to the cytosol. This process can be manipulated by molecular engineering of chimeric toxins. Using toxins with naturally unlinked components as a starting point is advantageous because it allows for the development of payloads separately from the binding/translocation components. Here the Clostridium botulinum C2 binding/translocation domain was retargeted to neural cell populations by deleting its non-specific binding domain and replacing it with a C. botulinum neurotoxin binding domain. This fusion protein was used to deliver fluorescently labeled payloads to Neuro-2a cells. Intracellular delivery was quantified by flow cytometry and found to be dependent on artificial enrichment of cells with the polysialoganglioside receptor GT1b. Visualization by confocal microscopy showed a dissociation of payloads from the early endosome indicating translocation of the chimeric toxin. The natural Clostridium botulinum C2 toxin was then delivered to human glioblastoma A172 and synchronized HeLa cells. In the presence of the fusion protein, native cytosolic enzymatic activity of the enzyme was observed and found to be GT1b-dependent. This retargeted toxin may enable delivery of therapeutics to peripheral neurons and be of use in addressing experimental questions about neural physiology.",
author = "Pavlik, {Benjamin J.} and Hruska, {Elizabeth J.} and {Van Cott}, Kevin and Blum, {Paul H}",
year = "2016",
month = "3",
day = "30",
doi = "10.1038/srep23707",
language = "English (US)",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Retargeting the Clostridium botulinum C2 toxin to the neuronal cytosol

AU - Pavlik, Benjamin J.

AU - Hruska, Elizabeth J.

AU - Van Cott, Kevin

AU - Blum, Paul H

PY - 2016/3/30

Y1 - 2016/3/30

N2 - Many biological toxins are known to attack specific cell types, delivering their enzymatic payloads to the cytosol. This process can be manipulated by molecular engineering of chimeric toxins. Using toxins with naturally unlinked components as a starting point is advantageous because it allows for the development of payloads separately from the binding/translocation components. Here the Clostridium botulinum C2 binding/translocation domain was retargeted to neural cell populations by deleting its non-specific binding domain and replacing it with a C. botulinum neurotoxin binding domain. This fusion protein was used to deliver fluorescently labeled payloads to Neuro-2a cells. Intracellular delivery was quantified by flow cytometry and found to be dependent on artificial enrichment of cells with the polysialoganglioside receptor GT1b. Visualization by confocal microscopy showed a dissociation of payloads from the early endosome indicating translocation of the chimeric toxin. The natural Clostridium botulinum C2 toxin was then delivered to human glioblastoma A172 and synchronized HeLa cells. In the presence of the fusion protein, native cytosolic enzymatic activity of the enzyme was observed and found to be GT1b-dependent. This retargeted toxin may enable delivery of therapeutics to peripheral neurons and be of use in addressing experimental questions about neural physiology.

AB - Many biological toxins are known to attack specific cell types, delivering their enzymatic payloads to the cytosol. This process can be manipulated by molecular engineering of chimeric toxins. Using toxins with naturally unlinked components as a starting point is advantageous because it allows for the development of payloads separately from the binding/translocation components. Here the Clostridium botulinum C2 binding/translocation domain was retargeted to neural cell populations by deleting its non-specific binding domain and replacing it with a C. botulinum neurotoxin binding domain. This fusion protein was used to deliver fluorescently labeled payloads to Neuro-2a cells. Intracellular delivery was quantified by flow cytometry and found to be dependent on artificial enrichment of cells with the polysialoganglioside receptor GT1b. Visualization by confocal microscopy showed a dissociation of payloads from the early endosome indicating translocation of the chimeric toxin. The natural Clostridium botulinum C2 toxin was then delivered to human glioblastoma A172 and synchronized HeLa cells. In the presence of the fusion protein, native cytosolic enzymatic activity of the enzyme was observed and found to be GT1b-dependent. This retargeted toxin may enable delivery of therapeutics to peripheral neurons and be of use in addressing experimental questions about neural physiology.

UR - http://www.scopus.com/inward/record.url?scp=84964018985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964018985&partnerID=8YFLogxK

U2 - 10.1038/srep23707

DO - 10.1038/srep23707

M3 - Article

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 23707

ER -